Dexrabeprazole/domperidone

Drug Profile

Dexrabeprazole/domperidone

Alternative Names: Dexpure-D; Domperidone/dexrabeprazole; Emrab-D

Latest Information Update: 10 Apr 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class 2 pyridinylmethylsulfinylbenzimidazoles; Piperidines; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists; Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Gastro-oesophageal reflux; Peptic ulcer

Most Recent Events

  • 31 Dec 2007 Launched for Peptic ulcer and Gastro-oesophageal reflux in India (PO, capsule)
  • 31 Dec 2007 Launched for Peptic ulcer and Gastro-oesophageal reflux in India (PO, tablet)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top